Hedera Dx (Series A)
Funding Details
Awarder
Inbox
Date Award
May 28, 2025
Vertical
Techbio
Funding URL
View Funding Page
Funding Amount
$15,000,000
Company Info
Traction
Hedera Dx's tests are already being used in 11 European countries, establishing itself as a leading platform for precision oncology.
Founders
Tommi Lehtonen, Christian Meisel
Market
Precision Oncology
Location
Vaud, Switzerland
Coinvestors
Vsquared Ventures, Tesi, Helsana HealthInvest, Eyrir Venture Management, Inventure, Top Harvest
Company Description

A diagnostics platform that makes liquid biopsies a reality in cancer care

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Techbio DealsView Funding Announcement